Chapter 5: Vaccines & Antimicrobial Agents

Vaccines & Antimicrobial Agents begins by contrasting passive immunization, which provides rapid but short-lived protection through preformed antibodies, with active immunization, which triggers the body’s own defenses to create enduring memory against future infections using live-attenuated, killed, or subunit-based preparations. The material outlines the diverse landscape of vaccine formulations, including conjugate vaccines that link polysaccharides to proteins to improve infant immunity and toxoids that neutralize bacterial secretions. Detailed attention is given to the global impact of vaccination on diseases such as measles, mumps, rubella, and poliomyelitis. Moving into pharmacology, the text establishes the concept of selective toxicity as the foundation for antimicrobial therapy, distinguishing between bactericidal agents that kill microbes and bacteriostatic agents that merely inhibit their reproduction. It categorizes major antibacterial families—including cell-wall inhibitors like penicillins and cephalosporins, protein synthesis inhibitors like aminoglycosides and tetracyclines, and DNA-disrupting fluoroquinolones—while also discussing specialized treatments like vancomycin for multidrug-resistant infections. A significant portion of the chapter is dedicated to the molecular basis of drug resistance, detailing how bacteria utilize genetic mutations and horizontal gene transfer via plasmids to alter drug targets, produce inactivating enzymes like beta-lactamases, or employ efflux pumps to decrease drug accumulation. The discussion concludes with the specialized challenges of antiviral therapy, highlighting strategies for managing chronic conditions such as HIV through multi-drug regimens, as well as treatments for herpes and viral hepatitis that target specific stages of the viral life cycle.